anmelden
NASDAQ Composite Index
25.870,71
PKT
-220,02
PKT
-0,84
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.12 | QUALCOMM hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | QUALCOMM buy | Nomura | |
| 06.11.12 | Amgen outperform | Credit Suisse Group | |
| 05.11.12 | Teva Pharmaceutical Industries outperform | RBC Capital Markets | |
| 05.11.12 | Microsoft sector perform | RBC Capital Markets | |
| 05.11.12 | Vertex Pharmaceuticals sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Starbucks buy | Deutsche Bank Securities | |
| 05.11.12 | ON Semiconductor buy | Jefferies & Company Inc. | |
| 05.11.12 | ON Semiconductor overweight | JP Morgan Chase & Co. | |
| 05.11.12 | Microsoft buy | Jefferies & Company Inc. | |
| 05.11.12 | Amazon halten | Der Aktionärsbrief | |
| 05.11.12 | Visa kaufen | Euro am Sonntag | |
| 05.11.12 | Visa outperform | Keefe, Bruyette & Woods, Inc. | |
| 05.11.12 | Microchip Technology neutral | Nomura | |
| 02.11.12 | Starbucks sector perform | RBC Capital Markets | |
| 02.11.12 | NuVasive underperform | RBC Capital Markets | |
| 02.11.12 | Vertex Pharmaceuticals buy | UBS AG | |
| 02.11.12 | Microchip Technology neutral | UBS AG | |
| 02.11.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 02.11.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 02.11.12 | Starbucks buy | UBS AG | |
| 02.11.12 | Royal Gold neutral | UBS AG | |
| 02.11.12 | Microsoft overweight | Morgan Stanley | |
| 02.11.12 | Visa buy | Nomura | |
| 02.11.12 | Visa outperform | Credit Suisse Group | |
| 02.11.12 | Cirrus Logic buy | Stifel, Nicolaus & Co., Inc. | |
| 02.11.12 | Visa strong buy | Raymond James Financial, Inc. | |
| 01.11.12 | Visa buy | Stifel, Nicolaus & Co., Inc. | |
| 01.11.12 | Netflix perform | Oppenheimer & Co. Inc. | |
| 01.11.12 | Visa sell | UBS AG | |
| 01.11.12 | Cirrus Logic strong buy | Needham & Company, LLC | |
| 01.11.12 | Amazon halten | Der Aktionär | |
| 31.10.12 | Alphabet A (ex Google) neutral | Frankfurter Tagesdienst | |
| 31.10.12 | Intuitive Surgical outperform | Barrington Research | |
| 31.10.12 | Apple overweight | Piper Jaffray & Co. | |
| 31.10.12 | Salesforce outperform | Barrington Research | |
| 31.10.12 | Microsoft buy | UBS AG | |
| 31.10.12 | Strategy (ex MicroStrategy) neutral | ROTH Capital Partners, LLC | |
| 31.10.12 | Ceragon Networks hold | Jefferies & Company Inc. |